Ostatní
Návod 
Inovio Pharmaceuticals, Inc.
INO
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.1B
Obrat
0B
Zisk
0B
Aktiva
69B
Dluh
10B
ROE
1%
ROA
-0%
PE
-9
PS
11337
Cena 1R
1-3
⌀ Cena
1.99
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
17-03-2026
Poslední dividenda
Profil
Inovio Pharmaceuticals, Inc., biotechnologická společnost, se zaměřuje na objevování, vývoj a komercializaci DNA léčiv pro léčbu a ochranu lidí před onemocněními spojenými s lidským papilomavirem (HPV), rakovinou a infekčními nemocemi. Jeho platforma pro léčivé přípravky DNA využívá přesně navržený SynCon, který identifikuje a optimalizuje DNA sekvenci cílového antigenu, stejně jako technologii chytrých zařízení CELLECTRA, která usnadňuje přenos DNA plazmidů. Společnost se zabývá prováděním a plánováním klinických studií svých DNA léků na prekancery spojené s HPV, včetně cervikální, vulvární a anální dysplazie; rakoviny spojené s HPV, jako jsou rakovina hlavy a krku, děložního čípku, konečníku, penilu, vulváru a vagíny; další poruchy spojené s HPV, včetně rekurentní respirační papilomatózy; glioblastoma multiforme; rakovina prostaty; HIV; ebola; blízkovýchodní respirační syndrom (MERS); a horečka Lassa. Mezi její partnery a spolupracovníky patří ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute z Alergie a infekčních nemocí, Ology Bioservices, Parkerův ústav pro onkologickou imunoterapii, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research a The Wistar Institute. Společnost uzavřela smlouvu s Richter-Helm BioLogics GmbH & Co. KG na podporu výzkumné vakcíny INO-4800 na COVID-19 a partnerství s International Vaccine Institute a Seoul National University Hospital. Společnost byla založena v roce 1979 a sídlí v Plymouth Meeting v Pensylvánii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
134
Založení
1998-12-08
Podobné společnosti
$ 1.88
- $ 0.02
$ 4.06
+ $ 0.08
$ 2.06
- $ 0.03
$ 1.07
- $ 0.00
$ 14.16
+ $ 0.14
$ 1.34
+ $ 0.06
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 65.34 | 65.34 | 217.76 | 832.01 | 10,262.27 | 1,774.76 | 7,411.22 | 4,111.93 | 30,481.90 | 42,220.09 | 35,368.36 | 40,572.11 | 10,456.77 | 13,467.35 | 4,118.65 | 9,795.26 | 6,144.71 | |
| Cost of Revenues | 1,495.72 | 0.00 | 0.00 | 3,503.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -1,430.38 | 65.34 | 217.76 | -2,671.53 | 10,262.27 | 1,774.76 | 7,411.22 | 4,111.93 | 30,481.90 | 42,220.09 | 35,368.36 | 40,572.11 | 10,456.77 | 13,467.35 | 4,118.65 | 9,795.26 | 6,144.71 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.00 | 0.00 | 0.00 | 65.34 | 116.99 | 0.00 | 100.76 | 0.00 | 102.65 | 388.45 | |
| Cost of Revenues | 754.05 | 0.00 | 741.67 | 0.00 | 775.83 | 0.00 | 828.63 | 0.00 | 175.23 | 1,032.78 | |
| Gross Profit | -754.05 | 0.00 | -741.67 | 65.34 | -658.84 | 0.00 | -727.86 | 0.00 | -72.58 | -644.33 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 86,676.56 | 187,650.50 | 249,240.32 | 94,245.44 | 88,017.32 | 95,257.88 | 98,572.62 | 88,712.04 | 57,791.92 | 34,095.04 | 21,368.60 | 17,984.83 | 20,032.00 | 13,256.61 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 47,582.10 | 90,185.29 | 53,752.35 | 37,247.83 | 27,203.16 | 29,315.16 | 28,290.37 | 23,892.26 | 18,063.89 | 15,857.69 | 13,643.07 | 10,778.36 | 11,988.80 | 12,108.26 | |
| Depreciation & Amortization | 2,988.83 | 2,988.83 | 3,130.04 | 3,503.54 | -979.21 | 7,883.66 | 47,912.47 | 5,528.07 | 4,996.77 | 3,469.04 | 3,085.96 | 1,918.63 | 1,569.27 | 2,099.29 | 1,994.92 | 2,011.71 | 2,108.54 | |
| Total Operating Expenses | 86,145.78 | 86,887.45 | 112,616.68 | 132,555.13 | 277,835.79 | 302,992.68 | 131,493.26 | 115,220.48 | 124,573.04 | 126,862.99 | 112,604.30 | 75,855.81 | 49,952.73 | 35,011.68 | 28,763.18 | 32,020.80 | 25,364.87 | |
| Operating Income | -86,822.10 | -86,822.10 | -112,398.92 | -135,226.66 | -267,573.52 | -301,217.92 | -124,082.04 | -111,108.55 | -94,091.14 | -83,642.90 | -76,235.94 | -34,283.70 | -39,495.96 | -19,544.33 | -23,493.53 | -21,638.54 | -19,220.16 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17,253.05 | 15,503.03 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,068.11 | 9,925.06 | ||
| Depreciation & Amortization | 754.05 | 749.66 | 741.67 | 743.45 | 775.83 | 765.86 | 828.63 | 759.73 | 175.23 | 1,032.78 | ||
| Total Operating Expenses | 17,476.60 | 21,210.46 | 22,342.85 | 25,115.87 | 19,710.73 | 27,347.48 | 32,469.05 | 31,484.97 | 27,321.16 | 35,941.46 | ||
| Operating Income | -17,476.60 | -21,210.46 | -23,084.52 | -25,050.53 | -20,369.56 | -27,347.48 | -33,196.91 | -31,484.97 | -27,393.74 | -35,553.01 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 553,976.05 | 2,420.16 | 4,766.99 | 8,133.29 | 4,782.03 | 3,363.08 | 3,311.85 | 2,605.98 | 0.00 | 1,612.97 | 0.00 | 305.07 | 0.00 | 132.21 | 166.11 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 177.83 | 1,222.79 | 1,253.95 | 1,936.45 | 8,702.45 | 7,948.54 | 346.09 | 4,562.87 | -2,495.60 | -5,175.89 | -3,355.83 | 88,171.87 | -4,931.55 | 34.29 | -1,506.90 | |
| Other Expense | 1,876.20 | 1,876.20 | 5,144.80 | 109.31 | -10,079.33 | -2,006.40 | -38,808.26 | -9,700.57 | -1,627.77 | -5,175.85 | 2,238.34 | 3,778.03 | 3,024.37 | -44,671.41 | 4,765.44 | 9,277.66 | 1,506.90 | |
| IBT | -84,945.90 | -84,945.90 | -107,254.13 | -135,117.35 | -277,652.85 | -303,224.32 | -162,890.30 | -120,809.11 | -94,798.02 | -88,205.77 | -73,740.34 | -31,200.60 | -36,140.13 | -66,083.53 | -19,712.98 | -12,947.88 | -17,713.26 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 10,011.39 | 2,160.64 | 52,196.14 | -257.34 | 2,169.81 | 1,756.05 | -4,623.15 | -2,097.77 | -3,722.39 | 88,116.79 | -8,109.20 | -16,284.54 | -4,083.18 | |
| Net Income | -84,945.90 | -84,945.90 | -107,254.13 | -135,117.35 | -287,664.24 | -305,384.96 | -215,086.44 | -120,551.78 | -96,967.83 | -88,205.77 | -73,740.34 | -29,187.61 | -36,121.71 | -66,028.45 | -19,668.96 | -15,252.95 | -17,613.80 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 449.34 | 552,108.00 | 610.64 | 808.08 | 852.59 | 1,106.76 | 1,307.36 | 1,500.29 | 1,819.14 | 1,938.75 | ||
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 177.83 | 282.33 | 313.49 | ||
| Other Expense | 21,241.48 | -24,286.22 | -434.89 | 5,355.83 | 987.88 | 2,182.00 | 959.82 | 1,015.10 | 2,390.10 | -8,890.22 | ||
| IBT | 3,764.88 | -45,496.67 | -23,519.41 | -19,694.70 | -19,381.68 | -25,165.48 | -32,237.10 | -30,469.87 | -25,003.64 | -33,929.86 | ||
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,032.78 | ||
| Net Income | 3,764.88 | -45,496.67 | -23,519.41 | -19,694.70 | -19,381.68 | -25,165.48 | -32,237.10 | -30,469.87 | -25,003.64 | -33,929.86 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-6.09 | $-14.47 | $-17.55 | $-16.64 | $-14.65 | $-1.05 | $-1.08 | $-1.01 | $-0.43 | $-0.61 | $-1.43 | $-0.58 | $-0.48 | $-0.68 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-6.09 | $-14.47 | $-17.55 | $-16.64 | $-14.65 | $-1.05 | $-1.08 | $-1.01 | $-0.43 | $-0.61 | $-1.43 | $-0.58 | $-0.48 | $-0.68 | |
| Shares Outstanding | 468,864.00 | 468,864.00 | 27,160.86 | 22,173.75 | 19,885.18 | 17,402.48 | 12,927.24 | 8,226.50 | 92,350.31 | 81,777.49 | 73,010.24 | 68,198.14 | 59,127.35 | 46,087.77 | 33,911.99 | 31,559.83 | 25,800.47 | |
| Diluted Shares Outstanding | 468,864.00 | 468,864.00 | 27,160.86 | 22,173.75 | 19,885.18 | 17,402.48 | 12,927.24 | 8,226.50 | 92,540.00 | 81,918.02 | 73,214.77 | 68,365.27 | 59,408.25 | 46,087.77 | 34,127.31 | 31,559.83 | 25,800.47 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.10 | $-1.52 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.10 | $-1.52 | ||
| Shares Outstanding | 468,864.00 | 52,169.00 | 38,830.05 | 27,160.86 | 27,160.86 | 28,140.50 | 27,197.80 | 23,291.51 | 22,793.17 | 22,385.23 | ||
| Diluted Shares Outstanding | 468,864.00 | 52,169.00 | 38,830.05 | 27,160.86 | 27,160.86 | 28,140.50 | 27,197.80 | 23,291.51 | 22,793.17 | 22,385.23 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 34,392.40 | 65,813.30 | 14,310.86 | 46,329.36 | 71,143.78 | 250,728.12 | 22,196.10 | 23,693.63 | 23,786.58 | 19,136.47 | 57,632.69 | 40,543.98 | 33,719.80 | 5,646.02 | 17,350.12 | 19,998.49 | |
| Short Term Investments | 76,029.12 | 28,300.23 | 130,982.91 | 206,669.40 | 330,170.94 | 160,914.94 | 67,338.02 | 57,538.85 | 103,638.84 | 85,629.41 | 105,357.28 | 53,075.97 | 18,905.61 | 8,034.00 | 12,863.42 | 1,846.27 | |
| Total Cash & ST Investments | 110,421.52 | 94,113.53 | 145,293.78 | 252,998.76 | 401,314.72 | 411,643.05 | 89,534.11 | 81,232.49 | 127,425.42 | 104,765.88 | 162,989.97 | 93,619.96 | 52,625.40 | 13,680.02 | 30,213.54 | 21,844.76 | |
| Accounts Receivable | 1,773.67 | 1,199.06 | 2,405.23 | 11,738.22 | 8,032.04 | 19,063.75 | 2,032.12 | 4,054.94 | 6,489.82 | 16,569.87 | 7,333.06 | 2,804.21 | 3,301.56 | 866.67 | 506.32 | 105.04 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 342.57 | 61.84 | 62.73 | 0.00 | 0.00 | |
| Other Current Assets | 5,365.86 | 2,517.47 | 5,414.10 | 50,505.71 | 39,098.18 | 40,463.89 | 2,634.74 | 2,527.40 | 4,446.91 | 3,261.48 | 1,527.91 | 2,180.35 | 2,694.78 | 1,358.50 | 1,187.24 | 927.41 | |
| Total Current Assets | 117,561.05 | 97,830.05 | 153,113.10 | 315,242.68 | 448,444.95 | 471,170.69 | 94,200.97 | 87,814.82 | 138,362.16 | 124,597.23 | 171,850.94 | 98,947.08 | 58,683.59 | 15,967.91 | 31,907.09 | 22,877.21 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 36,567,420.00 | 24,351.38 | 39,915.45 | 65,813.30 | 21,687.48 | 34,392.40 | 19,601.83 | 14,310.86 | 18,804.60 | 52,712.54 | |
| Short Term Investments | 14,235,770.00 | 23,198.08 | 28,447.10 | 28,300.23 | 63,117.29 | 76,029.12 | 86,013.04 | 130,982.91 | 148,668.87 | 142,212.91 | |
| Total Cash & ST Investments | 50,803,190.00 | 47,549.46 | 68,362.54 | 94,113.53 | 84,804.77 | 110,421.52 | 105,614.87 | 145,293.78 | 167,473.47 | 194,925.45 | |
| Accounts Receivable | 978,590.00 | 840.31 | 1,310.24 | 1,199.06 | 1,862.74 | 1,773.67 | 2,551.08 | 2,405.23 | 2,143.93 | 5,116.23 | |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,230.88 | |
| Other Current Assets | 3,398,534.00 | 4,307.38 | 2,221.67 | 2,517.47 | 4,617.12 | 5,365.86 | 3,517.08 | 5,414.10 | 5,149.80 | 3,242.81 | |
| Total Current Assets | 55,180,314.00 | 52,697.15 | 71,894.45 | 97,830.05 | 91,284.62 | 117,561.05 | 111,683.04 | 153,113.10 | 174,767.20 | 203,284.49 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 13,330.27 | 11,773.66 | 14,452.72 | 17,956.20 | 29,024.23 | 24,089.44 | 26,556.03 | 15,949.01 | 18,320.18 | 9,025.45 | 7,306.70 | 4,583.20 | 2,886.55 | 363.02 | 295.79 | 276.80 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 10,513.37 | 10,513.37 | 10,513.37 | 10,513.37 | 10,513.37 | 10,513.37 | 10,513.37 | 10,113.37 | 10,113.37 | 10,113.37 | 10,113.37 | 10,113.37 | 10,113.37 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 2,129.86 | 2,626.36 | 3,146.77 | 3,693.85 | 4,760.15 | 6,009.73 | 7,628.39 | 3,905.86 | 4,776.06 | 5,718.78 | 7,489.32 | 9,310.49 | 11,180.00 | |
| Long-Term Investments | 2,319.98 | 1,613.84 | 2,780.29 | 2,007.14 | 3,906.80 | 4,894.75 | 6,315.36 | 9,405.91 | 11,394.48 | 19,829.58 | 19,987.19 | 12,340.81 | 9,664.59 | 10,703.33 | 9,071.51 | 11,360.89 | |
| Other Long-Term Assets | 585.92 | 1,979.65 | 2,598.31 | 684.04 | 1,425.79 | 25,957.45 | 2,672.02 | 2,670.00 | 2,639.35 | 2,113.15 | 670.83 | -342,571,975.43 | 1,158.50 | 439.08 | 408.32 | 259.13 | |
| Total Long-Term Assets | 16,236.16 | 15,367.16 | 19,831.32 | 33,290.62 | 47,496.55 | 68,601.78 | 49,750.63 | 43,298.44 | 48,877.11 | 49,109.93 | 41,989.92 | 32,838.01 | 29,603.62 | 29,170.84 | 29,199.48 | 33,190.18 | |
| Total Assets | 133,797.20 | 113,197.21 | 172,944.42 | 348,533.30 | 495,941.49 | 539,772.47 | 143,951.60 | 131,113.27 | 187,239.27 | 173,707.17 | 213,840.86 | 131,785.10 | 88,287.21 | 45,138.75 | 61,106.56 | 56,067.39 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 9,697,136.00 | 10,445.53 | 11,089.58 | 11,773.66 | 12,564.41 | 13,330.27 | 14,171.55 | 14,452.72 | 14,729.79 | 15,792.69 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,513.37 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-Term Investments | 2,495,730.00 | 3,085.35 | 2,308.98 | 1,613.84 | 2,644.23 | 2,319.98 | 2,654.27 | 2,780.29 | 2,994.90 | 2,780.53 | |
| Other Long-Term Assets | 2,012,476.00 | 2,012.48 | 1,979.65 | 1,979.65 | 566.42 | 585.92 | 605.32 | 605.32 | 605.32 | 666.89 | |
| Total Long-Term Assets | 14,205,342.00 | 15,543.36 | 15,378.21 | 15,367.16 | 15,775.05 | 16,236.16 | 17,431.13 | 19,831.32 | 18,330.00 | 29,753.47 | |
| Total Assets | 69,385,656.00 | 68,240.50 | 87,272.66 | 113,197.21 | 107,059.67 | 133,797.20 | 129,114.17 | 172,944.42 | 193,097.20 | 233,037.96 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6,408.74 | 6,442.67 | 4,648.35 | 80,907.32 | 24,761.71 | 1,468.49 | 7,648.81 | 11,021.61 | 8,491.77 | 6,993.22 | 4,457.42 | 2,031.50 | 2,387.98 | 1,039.85 | 1,140.30 | 0.00 | |
| Short-Term Debt | 2,321.98 | 2,497.36 | 19,177.18 | 2,803.97 | 2,603.96 | 2,329.39 | 2,074.84 | 0.00 | 25,203.40 | 20,492.18 | 11,753.64 | 6,387.51 | 5,024.97 | 3,734.90 | 4,258.36 | 0.00 | |
| Other Current Liabilities | 17,669.05 | 26,385.56 | 18,744.71 | 13,156.78 | 38,354.34 | 37,861.45 | 22,141.54 | 24,021.00 | 360.80 | 1,167.61 | 1,301.14 | 2,022.73 | 19,540.58 | 2,859.90 | 5,176.32 | 5,640.81 | |
| Current Liabilities | 26,399.77 | 35,325.58 | 42,570.23 | 96,868.07 | 65,741.63 | 41,705.95 | 31,989.32 | 35,299.76 | 35,405.43 | 43,823.03 | 31,466.41 | 14,023.75 | 28,966.46 | 8,376.58 | 11,043.02 | 6,436.71 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.00 | 5,483.51 | 5,524.22 | 6,442.67 | 5,385.50 | 6,408.74 | 8,297.26 | 4,648.35 | 3,903.77 | 10,356.45 | |
| Short-Term Debt | 2,738,490.00 | 2,656.24 | 2,575.90 | 2,497.36 | 2,425.11 | 2,321.98 | 2,155.54 | 19,177.18 | 18,606.30 | 19,059.78 | |
| Other Current Liabilities | 67,085,406.00 | 23,567.86 | 19,226.76 | 26,385.56 | 15,688.53 | 17,669.05 | 12,948.14 | 18,744.71 | 21,200.95 | 22,516.08 | |
| Current Liabilities | 69,823,896.00 | 31,707.61 | 27,326.88 | 35,325.58 | 23,499.14 | 26,399.77 | 23,400.95 | 42,570.23 | 43,711.03 | 51,932.30 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 10,658.23 | 9,367.83 | 11,032.07 | 29,270.43 | 30,419.21 | 36,719.34 | 97,432.84 | 11,103.20 | 9,600.62 | 21,583.94 | 17,455.54 | 4,098.99 | 996.10 | -57.92 | -2,042.57 | -1,666.76 | |
| Capital Leases | 10,658.23 | 11,865.19 | 13,438.59 | 15,459.56 | 18,063.52 | 20,392.91 | 22,484.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 32.05 | 32.05 | 32.05 | 32.05 | 24.77 | 24.77 | 174.79 | 175.64 | 504.05 | 195.78 | 164.39 | 78.86 | 53.19 | |
| Total Liabilities | 37,058.00 | 44,693.41 | 55,595.29 | 126,170.55 | 96,272.07 | 78,631.71 | 138,546.74 | 44,080.86 | 44,750.46 | 50,328.75 | 37,907.81 | 20,247.50 | 35,384.52 | 10,281.35 | 13,244.90 | 8,966.48 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 7,281,737.00 | 8,001.99 | 8,695.06 | 9,367.83 | 10,020.23 | 10,658.23 | 11,271.26 | 11,032.07 | 11,194.41 | 11,702.04 | |
| Capital Leases | 10,020,227.00 | 10,658.23 | 11,270.96 | 11,865.19 | 12,445.34 | 12,980.21 | 13,426.80 | 11,032.07 | 13,312.38 | 14,053.49 | |
| Def. Tax Liability | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,993.00 | 32.05 | 32.05 | |
| Total Liabilities | 77,105,633.00 | 39,709.60 | 36,021.94 | 44,693.41 | 33,519.36 | 37,058.00 | 34,672.20 | 55,595.29 | 54,937.49 | 63,666.39 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 25.96 | 36.10 | 22.79 | 253.09 | 217.38 | 186.85 | 101.36 | 97.23 | 90.36 | 74.06 | 72.22 | 60.74 | 210.31 | 144.31 | 134.97 | 105.04 | |
| Retained Earnings | -1,685,672.11 | -1,730,219.26 | -1,622,965.14 | -1,487,847.78 | -1,209,855.52 | -906,196.81 | -739,785.66 | -620,426.44 | -523,356.32 | -434,838.24 | -361,097.90 | -331,910.29 | -295,788.58 | -229,760.13 | -210,091.17 | -194,838.23 | |
| Comprehensive Income | -689.54 | -675.67 | -662.60 | -698.74 | -282.24 | -256.15 | 472.61 | -528.87 | -117.01 | 1,327.97 | 2,708.34 | -251.39 | -76.37 | 73.36 | 35.39 | 2.85 | |
| Total Common Equity | 96,739.21 | 68,503.80 | 117,349.13 | 222,362.76 | 399,669.42 | 461,140.76 | 3,435.10 | 86,936.14 | 142,392.54 | 123,282.15 | 175,687.23 | 111,226.98 | 52,455.02 | 34,354.66 | 47,314.89 | 46,502.99 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 50,437,615.00 | 36.72 | 36.67 | 36.10 | 26.05 | 25.96 | 23.37 | 22.79 | 269.73 | 268.07 | |
| Retained Earnings | -1,818,930,043.00 | -1,773,433.37 | -1,749,913.96 | -1,730,219.26 | -1,710,837.58 | -1,685,672.11 | -1,653,435.01 | -1,622,965.14 | -1,597,961.50 | -1,564,031.63 | |
| Comprehensive Income | -647,356.00 | -661.74 | -661.32 | -675.67 | -623.46 | -689.54 | -676.21 | -662.60 | -751.07 | -691.26 | |
| Total Common Equity | -7,719,977.00 | 28,530.91 | 51,250.72 | 68,503.80 | 73,540.31 | 96,739.21 | 94,441.96 | 117,349.13 | 138,159.71 | 169,371.57 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 12,980.21 | 11,865.19 | 30,209.24 | 32,074.40 | 33,023.16 | 39,048.73 | 99,507.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book Value | 96,739.21 | 68,503.80 | 117,349.13 | 222,362.76 | 399,669.42 | 461,140.76 | 5,404.86 | 87,032.41 | 142,488.81 | 123,378.42 | 175,933.05 | 111,537.59 | 52,902.68 | 34,857.41 | 47,861.66 | 47,100.91 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book Value | -7,719,977.00 | 28,530.91 | 51,250.72 | 68,503.80 | 73,540.31 | 96,739.21 | 94,441.96 | 117,349.13 | 138,159.71 | 169,371.57 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -128,359.92 | -84,945.90 | -107,254.13 | -135,117.35 | -279,818.07 | -303,658.71 | -167,474.91 | -120,551.78 | -96,967.83 | -88,205.77 | -73,740.34 | -29,102.84 | -36,140.13 | -66,083.53 | -19,712.98 | -15,304.10 | -17,638.75 | |
| Depreciation & Amortization | 2,796.36 | 2,988.83 | 3,130.04 | 3,503.54 | 5,496.03 | 4,730.78 | 4,627.79 | 5,516.44 | 4,996.77 | 3,469.04 | 3,085.96 | 1,918.63 | 1,569.27 | 2,099.29 | 1,994.92 | 2,011.71 | 2,108.54 | |
| Stock-Based Compensation | 8,384.97 | 3,755.79 | 6,595.11 | 11,072.49 | 22,555.42 | 26,336.76 | 15,647.52 | 10,901.32 | 10,654.62 | 13,070.96 | 10,479.14 | 6,186.85 | 5,428.95 | 1,868.35 | 1,345.61 | 1,654.82 | 1,174.87 | |
| Change Working Capital | -8,567.54 | -9,218.81 | -2,664.95 | -10,259.69 | 19,834.15 | 50,351.45 | -71,071.82 | -3,543.12 | 4,709.42 | 2,895.76 | -546.16 | 13,639.35 | 2,166.43 | 1,674.52 | -1,190.56 | -1,276.71 | 3,649.11 | |
| Change In Accounts Receivable | 3,342.56 | 0.00 | 1,206.17 | 9,332.99 | -3,706.17 | 11,031.71 | -17,015.47 | 2,022.83 | 2,434.88 | 10,080.04 | -9,236.81 | -4,528.85 | 497.36 | -2,434.90 | -360.35 | 33.74 | 213.02 | |
| Change In Accounts Payable | -4,395.31 | -6,423.09 | -3,367.09 | -45,989.06 | 32,606.58 | 26,140.97 | 3,251.48 | -4,585.89 | 601.26 | 2,684.17 | 7,275.50 | 6,593.22 | 993.22 | 2,499.03 | -623.91 | -156.07 | -156.07 | |
| Change In Inventories | -1,767.14 | 0.00 | 0.00 | 0.00 | 0.00 | 15,548.02 | -55,153.62 | 935.79 | -963.92 | 531.87 | 592.02 | 1,049.23 | 441.94 | -1,604.17 | -97.19 | -410.00 | 718.29 | |
| Other Non-cash Items | 43,400.70 | -1,209.34 | -3,882.63 | 38,481.47 | 15,717.05 | 858.64 | 2,363.92 | 10,087.82 | -360.80 | 5,711.11 | -1,832.80 | -2,997.29 | -2,875.70 | 45,027.67 | -4,766.59 | -6,894.64 | -1,284.49 | |
| Cash from Operations | -120,085.41 | 0.00 | 0.00 | -124,365.55 | -216,215.42 | -215,708.53 | -177,979.05 | -97,850.14 | -73,550.16 | -63,208.92 | -62,555.05 | -12,438.90 | -29,823.64 | -15,381.44 | -22,306.79 | -19,755.72 | -11,937.53 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3,764.88 | -45,496.67 | -23,519.41 | -19,694.70 | -19,381.68 | -25,165.48 | -32,237.10 | -30,469.87 | -25,003.64 | -40,649.32 | |
| Depreciation & Amortization | 754.05 | 749.66 | 741.67 | 743.45 | 775.83 | 765.86 | 828.63 | 759.73 | 175.23 | 1,032.78 | |
| Stock-Based Compensation | 764.56 | 757.09 | 834.79 | 1,399.35 | 1,315.76 | 1,239.86 | 1,514.05 | 2,525.43 | 2,266.30 | 2,079.19 | |
| Change Working Capital | -3,808.75 | -730.43 | 94.36 | -4,773.99 | -731.05 | -2,859.46 | 1,776.81 | -851.25 | -2,111.07 | -7,382.03 | |
| Change In Accounts Receivable | 0.00 | -138.28 | 469.93 | -111.18 | 663.68 | -89.07 | 777.42 | -145.85 | -261.03 | 2,972.03 | |
| Change In Accounts Payable | -4,575.15 | -350.13 | 2,663.95 | -4,161.75 | 973.72 | -1,978.76 | 798.19 | -3,160.24 | 4,652.80 | -6,686.06 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,159.74 | -2,926.88 | |
| Other Non-cash Items | -20,845.29 | 23,146.86 | 1,037.23 | -4,548.14 | -1,642.78 | -1,424.11 | -91.74 | -724.00 | -1,570.56 | 36,840.31 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -26,275.79 | -36,840.31 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -166.93 | -285.70 | 0.00 | -320.90 | -969.15 | -1,231.01 | -1,520.67 | -987.93 | -2,085.02 | -10,293.90 | -3,938.47 | -2,781.54 | -1,379.98 | -176.93 | -240.99 | -161.19 | -306.63 | |
| Acquisitions | 148.26 | 0.00 | 0.00 | 0.00 | -2,000.00 | 1,435,821,000.00 | 38,725.42 | 987,926,000.00 | 2,779,494,000.00 | 0.00 | -1,200.00 | 0.00 | 1,379.98 | 0.00 | 0.00 | 0.00 | -124.98 | |
| Investments | -126,093.12 | -4,946.07 | -54,138.03 | -203,475.05 | -248,528.84 | -348,953.24 | -156,216.68 | -100,950.30 | -88,155.05 | -95,700.14 | -57,317.67 | -63,526.83 | -47,185.95 | -15,399.50 | -9,142.22 | -18,294.74 | -8,000.00 | |
| Sales of Investment | 196,231.08 | 19,271.13 | 158,637.58 | 284,932.56 | 361,083.85 | 174,839.76 | 62,991.02 | 92,893.23 | 132,659.98 | 77,162.90 | 76,528.03 | 10,484.27 | 12,753.72 | 4,339.58 | 14,008.77 | 7,206.00 | 19,710.00 | |
| Other Investing Activities | 311,884.55 | 0.00 | 0.00 | 6,219.26 | 0.00 | -1,435,821,000.00 | -2,774.85 | -987,926,000.00 | -2,779,494,000.00 | 1,000.00 | 2,200.00 | 1,000.00 | -1,379.98 | 2,000.00 | 650.00 | 350.00 | 157.48 | |
| Cash from Investing | 69,798.40 | 0.00 | 0.00 | 87,355.88 | 109,585.86 | -175,344.48 | -58,795.75 | -9,045.00 | 42,419.91 | -27,831.14 | 16,271.89 | -54,824.11 | -35,812.21 | -9,236.84 | 5,275.57 | -10,899.92 | 11,435.87 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -127.44 | -67.95 | -30.93 | -59.37 | 0.00 | 0.00 | -452.25 | -35.58 | 320.90 | 0.00 | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 148.26 | 0.00 | |
| Investments | 0.00 | 0.00 | -4,946.07 | 0.00 | 0.00 | -24,778.28 | -19,608.70 | -9,751.05 | -29,224.84 | -67,508.53 | |
| Sales of Investment | 69.26 | 8,935.18 | 10,259.07 | 7.62 | 34,585.00 | 38,856.05 | 30,027.27 | 55,169.26 | 49,019.86 | 62,014.70 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,038,630.55 | 0.00 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19,943.28 | -5,493.83 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -16,415.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -12,175.91 | |
| Debt Issued | -1,366.61 | 11,865.19 | -18,344.06 | -1,865.16 | -948.76 | -6,025.57 | -60,458.95 | 99,507.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12,175.91 | |
| Issuance of Common Stock | 41,045.44 | 0.00 | 0.00 | 5,461.75 | 82,955.31 | 209,441.41 | 454,486.40 | 9,089.01 | 29,227.78 | 94,347.92 | 6,295.76 | 81,902.36 | 59,209.18 | 32,883.71 | 5,325.14 | 27,994.60 | 2,314.12 | |
| Repurchase of Common Stock | 457.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,300,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 13,544,014.79 | 0.00 | 0.00 | -466.65 | -1,114.61 | 2,057.39 | 10,793.21 | 96,308.59 | 1,809.53 | 1,342.25 | -4,299,998,508.82 | 2,449.36 | 13,252.54 | 19,808.23 | 0.00 | 15.93 | 168.67 | |
| Cash from Financing | 24,206.41 | 0.00 | 0.00 | 4,995.10 | 81,840.70 | 211,498.80 | 465,279.61 | 105,397.60 | 31,037.30 | 95,690.17 | 7,786.94 | 84,351.72 | 72,461.73 | 52,691.94 | 5,325.14 | 28,010.53 | -9,693.12 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Debt Issued | 10,020,227.00 | 10,009,568.77 | -612.73 | -594.23 | -580.15 | -534.87 | -446.59 | -16,782.45 | 408.53 | -961.11 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,838.28 | 708.28 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -9.65 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,838.28 | 698.63 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -71,049.88 | -21,539.98 | 51,502.44 | -32,018.50 | -24,814.42 | -179,584.34 | 228,532.02 | -1,497.54 | -92.95 | 4,650.11 | -38,496.22 | 17,088.71 | 6,824.19 | 28,073.78 | -11,704.10 | -2,648.37 | -10,297.73 | |
| Closing Cash Balance | 34,392.40 | 44,273.32 | 65,813.30 | 14,310.86 | 46,329.36 | 71,143.78 | 250,728.12 | 22,196.10 | 23,693.63 | 23,786.58 | 19,136.47 | 57,632.69 | 40,543.98 | 33,719.80 | 5,646.02 | 17,350.12 | 19,998.49 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 7,705.90 | 12,216.04 | -15,564.07 | -25,897.85 | 44,125.82 | -12,704.92 | 14,790.58 | 5,290.97 | -4,493.74 | -86,637.68 | |
| Closing Cash Balance | 44,273.32 | 36,567.42 | 24,351.38 | 39,915.45 | 65,813.30 | 21,687.48 | 34,392.40 | 19,601.83 | 14,310.86 | -33,925.14 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -120,252.34 | -88,915.13 | -104,564.39 | -124,686.45 | -217,184.57 | -216,939.53 | -179,499.71 | -98,838.06 | -75,635.18 | -73,502.82 | -66,493.52 | -15,220.45 | -31,203.62 | -15,558.36 | -22,547.77 | -19,916.90 | -12,244.16 | |
| Real Free Cash Flow | -128,637.31 | -92,670.92 | -111,159.49 | -135,758.94 | -239,739.99 | -243,276.30 | -195,147.23 | -109,739.38 | -86,289.80 | -86,573.79 | -76,972.66 | -21,407.29 | -36,632.57 | -17,426.71 | -23,893.38 | -21,571.73 | -13,419.02 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -19,497.99 | -21,641.45 | -20,842.29 | -26,933.40 | -19,663.91 | -27,443.34 | -28,661.60 | -28,795.53 | -25,954.89 | -36,840.31 | |
| Real Free Cash Flow | -20,262.55 | -22,398.53 | -21,677.08 | -28,332.75 | -20,979.67 | -28,683.20 | -30,175.66 | -31,320.97 | -28,221.19 | -38,919.50 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -8.7 | -91 | -1.4 |
| P/S | 11337.2 | 1183.3 | 9.4 |
| P/B | -0.1 | 59.6 | 5.2 |
| P/FCF | -8 | -103.3 | -1.5 |
| Market cap | $0.1 | $0.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 14.4 % | 195.5 % | 0 % |
| Debt to Income | -11796 % | -169.8 % | 0 % |
| Debt to Free cash flow | -10812.7 % | -21142.9 % | 0 % |
| Interest expense percentage | 0 % | -18 % | 44.7 % |
| Current ratio | 0.8 | 5 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 1.1 % | -3088.3 % | 0 % |
| ROA | -0.1 % | -1395.8 % | 0 % |
| CapEx to Revenue | 86.8 % | 4 % | 0 % |
| RaD to Revenue | 0 % | 265055.3 % | 0 % |
| ROEM | 487.6 | 91840.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | -732.2 % | -108.3 % | 68.7 % |
| Operating margin | -49202.9 % | -191653.1 % | 35.5 % |
| Net margin | -59281.7 % | -921655.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 52.2 mil | 80.1 mil |
| Employee count | 0.1 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
